Meet Reliant AI at ESMO Congress 2025


Reliant AI transforms how oncology teams find and synthesize evidence, accelerating review and extraction workflows. We’ll be at ESMO 2025 to share how leading biopharma teams are using AI to gain back time and increase the precision of their work.

Meet Us In Berlin
Trusted by life sciences leaders:

Meet Team Reliant in Berlin

Join us at ESMO 2025 to discuss collaboration opportunities and see how AI is accelerating innovation in oncology research.

[headshot] image of customer (for a plumbing service)
Charlotte Decaudaveine
Account Executive
[headshot] image of customer sharing feedback (for a environmental conservation nonprofit)
Richard Schlegel
Co-Founder and Head of Commercial
image of founder [headshot]
Joe Baston
Senior Technical Product Manager
Featured Research

Addressing Challenges in Determining Line of Therapy with Large Language Models

Our latest study for at ESMO 2025 shows how Reliant’s fine-tuned AI agent outperforms existing tools in determining line of therapy (LoT) from clinical trials — achieving 76% accuracy, compared to 35% with standard models. Curious to learn more? The abstract is avaliable digitally.

Read Now
Testimonial

"With Reliant Tabular, we’ve been able to focus our time and energy on synthesizing high-quality outputs from data rather than menially sifting through it."

Director
OMass Therapeutics

Contact us

Ready to speed up without slipping up?

Let Reliant help you focus on what you do best — with faster, safer, traceable AI.

Thank you! We will respond shortly.
image of team brainstorming session (for a graphic design studio)
Submission unsuccessful. Please check your information.